# FDA Inspection 1251061 - Cyril D. Mazer, M.D. - September 19, 2024

Source: https://www.keypedia.com/records/fda_inspections/cyril-d-mazer-md/57e37a17-9365-41af-9ed6-4aa99c892a25
Source feed: FDA_Inspections

> FDA Inspection 1251061 for Cyril D. Mazer, M.D. on September 19, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1251061
- Company Name: Cyril D. Mazer, M.D.
- Inspection Date: 2024-09-19
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1251061 - 2024-09-19](https://www.keypedia.com/records/fda_inspections/cyril-d-mazer-md/4c97c8e4-fb57-4257-9ba3-fdc63c3eab46)

Company: https://www.keypedia.com/companies/cyril-d-mazer-md/c0f7d9e6-1fc8-4647-8b6c-44b0bb17271c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c